AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Orum Therapeutics, Inc.

₩49950 -$63850.00 (-56.11%)
KOE · 14 Sep 2026 06:30 UTC
Previous Close
₩51000
Day Range
₩48250₩50700
Year Range
₩31250₩146600
Market Cap
1.06T
AVG Volume
181.44K
Trailing/Forward PE
57.9/-
PEG ratio
-0.1
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
KOSDAQKR
Revenue (KRW) · TTM
050B100B150B200B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Revenue (KRW) · TTM by quarter
PeriodRevenue (KRW) · TTM
26 Q240.55M
26 Q120.61M
25 Q423.56M
25 Q325.47M
25 Q220.88B
25 Q120.89B
24 Q420.91B
24 Q3155.51B
24 Q2134.66B
24 Q1134.69B
Net Income (KRW) · TTM
-50B050B100B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Net Income (KRW) · TTM by quarter
PeriodNet Income (KRW) · TTM
26 Q218.51B
26 Q1-48.65B
25 Q4-41.97B
25 Q3-36.81B
25 Q2-8.76B
25 Q1-6.69B
24 Q4-5.63B
24 Q398.85B
24 Q275.19B
24 Q168.6B
Operating Income (KRW) · TTM
-100B-50B050B100B150B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Operating Income (KRW) · TTM by quarter
PeriodOperating Income (KRW) · TTM
26 Q2-65.62B
26 Q1-60.27B
25 Q4-51.76B
25 Q3-40.34B
25 Q2-12.97B
25 Q1-8.83B
24 Q4-5.22B
24 Q3120.94B
24 Q2100.68B
24 Q1100.69B
EBITDA (KRW) · TTM
-50B050B100B150B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ EBITDA (KRW) · TTM by quarter
PeriodEBITDA (KRW) · TTM
26 Q221.5B
26 Q1-45.6B
25 Q4-38.97B
25 Q3-29.38B
25 Q2-3.37B
25 Q1-6.68B
24 Q4-5.39B
24 Q3120.85B
24 Q2100.56B
24 Q198.54B
Cash Flows (KRW) · TTM
-100B-50B050B100B150B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Cash Flows (KRW) · TTM by quarter
PeriodCash Flows (KRW) · TTM
26 Q2-52.74B
26 Q1-44.68B
25 Q4-36.68B
25 Q3-35.24B
25 Q2-16.83B
25 Q1-13.65B
24 Q4-12.44B
24 Q3115.07B
24 Q295.5B
24 Q194.89B
EPS (KRW) · TTM
-4000-200002000400024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ EPS (KRW) · TTM by quarter
PeriodEPS (KRW) · TTM
26 Q2862.35
26 Q1-2254.38
25 Q4-2010.38
25 Q3-1845.85
25 Q2-426.85
25 Q1-380.77
24 Q4-1598.86
24 Q33469.37
24 Q22253.66
24 Q12111.16
Expenses (KRW) · TTM
-20B020B40B60BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Expenses (KRW) · TTM by quarter
PeriodExpenses (KRW) · TTM
26 Q255.36B
26 Q150.31B
25 Q442.21B
25 Q332.1B
25 Q226.1B
25 Q121.94B
24 Q418.26B
24 Q315.47B
24 Q217.22B
24 Q118.41B
Shares Outstanding · TTM
-1B-750M-500M-250M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
475830.KQ Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
26 Q2-748.16M
26 Q1-850.74M
25 Q4-867.79M
25 Q3-713.07M
25 Q2-278.84M
25 Q1-176.26M
24 Q40
24 Q30
24 Q20
24 Q10
PE Ratio
4567med 5.16Feb 25Feb 25Feb 25Mar 25Mar 25Mar 25Mar 25
475830.KQ PE Ratio by quarter
PeriodPE Ratio
Mar 255.08
Mar 254.49
Mar 255.68
Mar 255.16
Feb 256.35
Feb 256.37
Feb 254.12
Free Cash Flow Yield
-10%0%10%20%30%med -2.35%Apr 25Jul 25Oct 25Jan 26Mar 26Jun 26Sep 26
475830.KQ Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-3.88%
Sep 26-3.54%
Aug 26-3%
Aug 26-3.19%
Aug 26-2.91%
Aug 26-3.2%
Jul 26-4.44%
Jul 26-4.35%
Jul 26-4.36%
Jul 26-4.06%
Jul 26-3.79%
Jun 26-3.5%
Jun 26-2.79%
Jun 26-2.54%
Jun 26-2.74%
May 26-2.55%
May 26-2.4%
May 26-2.27%
May 26-2.09%
Apr 26-1.96%
Apr 26-2.05%
Apr 26-2.01%
Apr 26-2%
Apr 26-2.17%
Mar 26-1.49%
Mar 26-1.32%
Mar 26-1.2%
Mar 26-1.43%
Feb 26-1.28%
Feb 26-1.52%
Feb 26-1.45%
Feb 26-1.53%
Jan 26-1.48%
Jan 26-1.42%
Jan 26-1.37%
Jan 26-1.16%
Jan 26-1.47%
Dec 25-0.77%
Dec 25-0.76%
Dec 25-0.87%
Dec 25-0.97%
Nov 25-1.4%
Nov 25-1.44%
Nov 25-1.53%
Nov 25-1.57%
Oct 25-1.74%
Oct 25-2.35%
Oct 25-2.48%
Oct 25-2.28%
Oct 25-2.36%
Sep 25-2.16%
Sep 25-1.91%
Sep 25-2.13%
Sep 25-2.24%
Aug 25-2.67%
Aug 25-2.74%
Aug 25-2.71%
Aug 25-2.97%
Aug 25-3.31%
Jul 25-2.92%
Jul 25-2.99%
Jul 25-3.29%
Jul 25-3.75%
Jun 25-3.58%
Jun 25-3.75%
Jun 25-3.79%
Jun 25-3.97%
May 25-3.5%
May 25-3.7%
May 25-3.2%
May 25-3.97%
May 25-3.71%
Apr 25-2.65%
Apr 25-2.45%
Apr 25-2.42%
Apr 25-2.41%
Mar 2522.92%
Mar 2525.9%
Mar 2520.48%
Mar 2522.58%
Feb 2518.35%
Feb 2518.26%
Feb 2528.28%
Price to Sales
050000100000150000med 57.53Apr 25Jul 25Oct 25Jan 26Mar 26Jun 26Sep 26
475830.KQ Price to Sales by quarter
PeriodPrice to Sales
Sep 2655868.71
Sep 2661236.49
Aug 2672300.69
Aug 2667918.83
Aug 2674601.16
Aug 2667809.28
Jul 2648857.74
Jul 2649843.66
Jul 2649734.11
Jul 2653349.14
Jul 2657183.27
Jun 2644421.4
Jun 2655864.65
Jun 2661180.8
Jun 2656855.79
May 2661090.69
May 2664784.97
May 2668479.24
May 2674336.02
Apr 2679471.96
Apr 2675957.9
Apr 2677399.57
Apr 2677759.98
Apr 2671903.21
Mar 2693023.57
Mar 26104527.38
Mar 26115451.85
Mar 2697078.87
Feb 26107837.82
Feb 2690789.02
Feb 2695589.17
Feb 2690209.69
Jan 2693520.14
Jan 2697244.39
Jan 26100803.12
Jan 26118927.82
Jan 2694182.23
Dec 25105.27
Dec 25105.97
Dec 2592.25
Dec 2582.96
Nov 2557.53
Nov 2556.01
Nov 2552.58
Nov 2551.27
Oct 2546.43
Oct 2534.31
Oct 2532.45
Oct 2535.37
Oct 2534.16
Sep 2530.25
Sep 2534.24
Sep 2530.63
Sep 2529.2
Aug 2524.45
Aug 2523.88
Aug 2524.11
Aug 2521.97
Aug 2519.74
Jul 2522.35
Jul 2521.88
Jul 2519.83
Jul 2517.43
Jun 2516.62
Jun 2515.89
Jun 2515.69
Jun 2514.99
May 2517
May 2516.1
May 2518.62
May 2515
May 2516.02
Apr 2522.45
Apr 2524.26
Apr 2524.57
Apr 2524.74
Mar 253.23
Mar 252.86
Mar 253.61
Mar 253.28
Feb 254.03
Feb 254.05
Feb 252.62
EV/EBITDA
2.533.544.5med 3.4Feb 25Feb 25Feb 25Mar 25Mar 25Mar 25Mar 25
475830.KQ EV/EBITDA by quarter
PeriodEV/EBITDA
Mar 253.34
Mar 252.86
Mar 253.83
Mar 253.4
Feb 254.38
Feb 254.4
Feb 252.55
Price/Operating Cashflow
3.544.555.56med 4.5Feb 25Feb 25Feb 25Mar 25Mar 25Mar 25Mar 25
475830.KQ Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Mar 254.44
Mar 253.92
Mar 254.96
Mar 254.5
Feb 255.54
Feb 255.57
Feb 253.59
Price to Book
0100002000030000med 7.64Apr 25Jul 25Oct 25Jan 26Mar 26Jun 26Sep 26
475830.KQ Price to Book by quarter
PeriodPrice to Book
Sep 269.63
Sep 2610.56
Aug 2612.46
Aug 2611.71
Aug 2612.86
Aug 2611.69
Jul 268.42
Jul 268.59
Jul 268.57
Jul 269.2
Jul 269.86
Jun 2611590.34
Jun 2614576.09
Jun 2615963.17
Jun 2614834.7
May 2615939.66
May 2616903.56
May 2617867.46
May 2619395.6
Apr 2620735.66
Apr 2619818.78
Apr 2620194.94
Apr 2620288.98
Apr 2618760.84
Mar 2623016.68
Mar 2625863.05
Mar 2628566.08
Mar 2624020.08
Feb 2626682.15
Feb 2622463.79
Feb 2623651.48
Feb 2622320.45
Jan 2623139.55
Jan 2624061.03
Jan 2624941.56
Jan 2629426.13
Jan 2623303.37
Dec 2513.98
Dec 2514.08
Dec 2512.25
Dec 2511.02
Nov 257.64
Nov 257.44
Nov 256.99
Nov 256.81
Oct 256.17
Oct 254.56
Oct 254.31
Oct 254.7
Oct 254.54
Sep 253.91
Sep 254.42
Sep 253.96
Sep 253.77
Aug 253.16
Aug 253.08
Aug 253.11
Aug 252.84
Aug 252.55
Jul 252.89
Jul 252.83
Jul 252.56
Jul 252.25
Jun 252.87
Jun 252.75
Jun 252.71
Jun 252.59
May 252.94
May 252.78
May 253.22
May 252.59
May 252.77
Apr 253.88
Apr 254.19
Apr 254.24
Apr 254.27
Mar 253.84
Mar 253.4
Mar 254.3
Mar 253.9
Feb 254.79
Feb 254.82
Feb 253.11
Orum Therapeutics, Inc.
475830.KQ
Stockpicker

Video analysis: 475830.KQ

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.